Alyeska Investment Group L.P. Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Alyeska Investment Group L.P. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 59.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 57,802 shares of the healthcare conglomerate's stock after selling 84,694 shares during the period. Alyeska Investment Group L.P.'s holdings in UnitedHealth Group were worth $29,240,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Western Pacific Wealth Management LP increased its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after buying an additional 19 shares during the last quarter. MCF Advisors LLC raised its position in shares of UnitedHealth Group by 0.8% during the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock valued at $1,304,000 after acquiring an additional 20 shares in the last quarter. Axiom Financial Strategies LLC boosted its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after purchasing an additional 20 shares during the period. Richwood Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares during the period. Finally, Prentice Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after buying an additional 21 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UNH traded down $9.60 during trading hours on Tuesday, hitting $395.21. The company's stock had a trading volume of 7,831,081 shares, compared to its average volume of 4,638,108. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $393.11 and a 12 month high of $630.73. The business's 50-day moving average price is $494.68 and its 200-day moving average price is $527.03. The stock has a market cap of $359.73 billion, a price-to-earnings ratio of 25.50, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the business posted $6.91 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Analyst Ratings Changes

A number of analysts have recently weighed in on UNH shares. KeyCorp dropped their price target on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Truist Financial cut their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday, April 21st. Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. decreased their price objective on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.